Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients wit
about
Richter transformation of CLL.The value of rituximab for the treatment of fludarabine-refractory chronic lymphocytic leukemia: a systematic review and qualitative analysis of the literature.Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia.Phase I-II clinical trial of oxaliplatin, fludarabine, cytarabine, and rituximab therapy in aggressive relapsed/refractory chronic lymphocytic leukemia or Richter syndrome.Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter's syndrome.A Rare Cause of Cavitary Lesion in the Lung: Richter's Transformation.Stem cell transplantation for chronic lymphocytic leukemia: should not more patients get a transplant?State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia.The role of allogeneic transplantation in non-Hodgkin's lymphoma.Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukemia.Novel targeted treatment strategies for refractory chronic lymphocytic leukaemia.Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015How we treat Richter syndrome.A systematic review on Richter syndrome: what is the published evidence?Treatment of patients with fludarabine-refractory chronic lymphocytic leukemia: need for new treatment options.Refractory chronic lymphocytic leukemia--new therapeutic strategies.Salvage therapy for relapsed chronic lymphocytic leukemia.Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.An update for Richter syndrome - new directions and developments.Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma.Herpes simplex infection simulating Richter transformation: a series of four cases and review of the literature.Richter Syndrome in Chronic Lymphocytic Leukemia.NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome.Early detection of Richter's transformation: stable disease with dose-reduced gemcitabine and local radiation.Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant.Platinum and high-dose cytarabine-based regimens are efficient in ultra high/high-risk chronic lymphocytic leukemia and Richter's syndrome: results of a French retrospective multicenter study.Ibrutinib has some activity in Richter's syndromeA phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma.A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor.Treatment of Richter's Syndrome.Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies.Polymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population.
P2860
Q30249283-60F713FF-7913-4E7F-8B44-1B93EE18D13DQ31033615-5E652B18-E7D4-483D-BA4C-36E0B4248CFEQ34009015-F367A3A0-5221-40F4-AF20-531ABF9510EFQ34269186-80EF2C60-60C1-4B38-B0F5-FE737227A380Q35086905-22AB2ACF-2A6B-4F35-AEE5-0649CB9FDC19Q35163230-34834949-4B91-42B6-80B9-8C9DDE8B0DD8Q35819325-6FEE05CC-20CC-4963-B43D-20A8219AAE7FQ35860550-F55102CD-E859-4F77-B676-E2A0C5876BD4Q36003103-4FCC43FF-75FA-4722-84FC-95D848F72C63Q36069481-F38AC543-6DAD-49A5-B57A-217FCBA216C4Q36612602-9C054BB8-0E7C-4C16-81F6-82183E168E88Q36826893-FC5207CE-3002-4FD3-A326-061395D42C41Q37636962-A50FC995-8380-4045-A58B-E3FDE3BAD775Q37676244-1E3BB9FB-AB05-4634-B351-7EC311B177C8Q37764869-293A24F3-E897-4317-8165-EAF2C9FB1F05Q37840932-73DDC73A-672C-4EBA-923C-2F34F0AB2C03Q37865547-D171A37F-0DE6-4940-AA60-F98AAC48A175Q38263924-FBD74E38-A82F-4317-9FA9-AFAE155927DFQ38691261-066898E6-0ED1-449B-97C2-3BBD7CC5EAD3Q38896306-3C3B2F55-B41A-4A00-AA94-1D2A0F6B5655Q39025300-5DA5CD2B-4C97-4CED-AD50-4C6DC3F0CDA2Q40037434-9EF670CC-EC6D-4BF6-8D25-D7A5334A2B3AQ40098409-CDD28078-0EED-4667-BB77-6ED9AE631141Q40466179-64336B95-33EC-429B-9848-F36CAB422958Q40955026-E54729A2-A2A5-4116-ACE9-9A5A365499BAQ41682806-7C9A0DE2-8802-4B23-BA66-91459CCE1F2BQ42358968-26841970-5539-4784-9DD9-1B7E470772EDQ46606526-B44F48BE-37E5-444B-9094-7CB7B2F02E13Q48204203-BA59C55E-91C6-4B35-AD92-3E3F5DC5DEF8Q49843910-C080A5A3-3805-4721-A0DA-134C7C640809Q50074012-F5856557-F521-40B1-8614-263A74DFEA10Q51582270-EC2158BE-C653-4AAB-97F1-DF858721A918
P2860
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients wit
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Fractionated cyclophosphamide, ...... mab and GM-CSF in patients wit
@en
Fractionated cyclophosphamide, ...... mab and GM-CSF in patients wit
@nl
type
label
Fractionated cyclophosphamide, ...... mab and GM-CSF in patients wit
@en
Fractionated cyclophosphamide, ...... mab and GM-CSF in patients wit
@nl
prefLabel
Fractionated cyclophosphamide, ...... mab and GM-CSF in patients wit
@en
Fractionated cyclophosphamide, ...... mab and GM-CSF in patients wit
@nl
P2093
P50
P356
P1433
P1476
Fractionated cyclophosphamide, ...... mab and GM-CSF in patients wit
@en
P2093
Deborah A Thomas
Francis J Giles
Susan M O'Brien
Yesid Alvarado
P304
P356
10.1002/CNCR.11238
P407
P50
P577
2003-04-01T00:00:00Z